ClinicalTrials.gg
Sign In

Rubella clinical trials

The registry lists 85 studies for Rubella across more than 10 countries. 11 are recruiting or about to start. 10 of them are mainly about Rubella (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-24.

Get an email when these change. Save the Rubella studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
65
Not yet recruiting
6
Status unknown
5
Recruiting
5
Terminated
3
Withdrawn
1

Phase

Phase 3
40
Phase 4
18
Phase 2
14
Phase 1
3

Where

United States
21
Puerto Rico
8
Germany
8
China
6
Italy
6
Finland
5

Who runs them

GlaxoSmithKline (22) · Merck Sharp & Dohme LLC (18) · Sanofi Pasteur, a Sanofi Company (6) · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (5) · International Centre for Diarrhoeal Disease Research, Bangladesh (2) · PATH (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Takeda (2)

What is being tested here

Drugs under test in Rubella studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Yellow Fever Vaccine122
Inactivated SARS-CoV-2 Vaccine101
Measles-Mumps-Rubella Vaccine0813
Measles, mumps, rubella, varicella vaccine0911
Measles Vaccine012
Rubella Vaccine012
Chickenpox Vaccine002
Adenosine Monophosphate011
Diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine011

Coming up

5phase 3 studies under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 5 Rubella studies recruiting now, 0 (0%) set no upper age limit and 5 (100%) stop at 75 or younger. 4 (80%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (60%) take healthy volunteers.

Recruiting studies that take each age, of 5
AgeWomenMen
103 (60%)3 (60%)
183 (60%)3 (60%)
302 (40%)2 (40%)
402 (40%)2 (40%)
501 (20%)1 (20%)
651 (20%)1 (20%)
751 (20%)1 (20%)
850 (0%)0 (0%)

Across all 85 studies, recruiting or not: 91% stop at 75 or younger and 88% at 65; 93% take children; 2% are for women only and 1% for men only; 92% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Rubella studies take

Of 15 phase 3 interventional studies under Rubella, half reached primary completion within 13 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 313 mo8–15 · 15 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 85. Browse all 85 → or search them.